Background
Chronic kidney disease (CKD) is a condition with significant social impact, which poses a serious health and social problem, affecting patients' lives. It is marked by a progressive loss of the renal function, and kidney damage over a period of months or years. Typically, the glomerular filtration rate is reduced and the serum creatinine and urea levels are increased. The most common causes contributing to this condition are diabetes mellitus, chronic glomerulonephritis, chronic interstitial nephrites, arterial hypertension, and autoimmune conditions (1,2). About 8 % of the human population (over 550 mln. people) are affected by the disease. CKD incidence is approximately 120 people per million population. The rate of disease in Bulgaria is nearly 10% (about 700 000-750 000 people). In 2015, the total number of patients treated in dialysis centres across the country was 4,000 people. Of those, 90% are with terminal kidney failure and are on substitutive dialysis treatment. According to epidemiological data, the disease incidence, increases with age. Men are affected more often than women. Research has been made into the incidence of disease relative to ethnicity. In the US, according to written sources, mortality from CKD in the Asian race is lower than in the white Caucasian race (2, 3).
The questions linked to clarifying oral, dental and bone changes in patients with CKD, who are undergoing substitutive CHD (chronic haemodialysis) treatment are the subject of scientific research and developments but there are still unresolved issues in this regard. There are not many reports in medical literature regarding the use of salivary biomarkers as a diagnostic instrument in the evaluation of various systemic conditions, or for monitoring patients undergoing chronic haemodialysis.
Review Results
Chronic kidney disease can affect a wide range of tissues and systems. It directly or indirectly affects flow, concentrations and composition of saliva. In this review we would like to present the salivary biomarkers in patients with CKD.
Salivary concentrations of Na, P, K, Ca and urea
Bella Ram Anuradha and coworkers have studied non-stimulated saliva from 50 patients with CKD undergoing substitutive treatment and found that the examined levels of Na, P, K, Ca, and urea in the saliva were considerably higher in patients with CKD, compared to the control group of healthy individuals. They found that the heightened levels in patients undergoing substitutive treatment, correlated to the severity of the kidney disease (4).
Salivary concentrations of creatinine and urea
In 2016, Taye Jemilat Lasisi et al. reported on research that proved that the salivary levels of creatinine and urea in patients with CKD reflected their levels in the blood. The authors concluded that salivary concentrations can be used as diagnostic biomarkers in chronic kidney disease, and can take prevalence over serum tests. The positive correlation between blood and saliva tests for creatinine and urea, Salivary concentrations of urea, creatinine, Na, K, and phosphate C. Seethalakshmi and associates conducted a comparative study of patients with end-stage CKD for urea, creatinine, Na, K, and phosphate values in both serum and saliva, before and after substitutive treatment. Lower values were recorded for the tested indices in blood and saliva analysed before substitutive treatment, compared to the same, tested after it was conducted (7).
Salivary concentrations of urea and nitrates (NO2-)
In 2008, Blicharz TM and associates tested nitrates NO2-and urea in saliva samples taken from patients with end-stage kidney disease. The average salivary concentrations of the indices they analysed, were shown to go down with the length of dialysis, by 86% (nitrates) and 39% (urea). The authors concluded that salivary biomarker measurment can be an efficient alternative means of monitoring haemodialysis effectiveness (8) .
Salivary concentrations of urea and potassium
Rafael M. Nagler and associates found in their research a very high correlation ratio between serum tested and saliva tested urea and potassium, and also recommended the use of salivary urea as a marker in the evaluation of dialysis treatment (9) .
Salivary concentrations of urea
Suresh G. et al. also proved a correlation between the levels of urea in saliva and blood in patients undergoing haemodialysis as a result of CKD. The authors reached the conclusion that salivary tests for urea can replace the conventional blood tests (with priority particularly for children on substitutive treatment) (10) .
Conclusion
All of the above data confirm the extraordinary opportunity in using the biological contents of the oral cavity instead of the conventional blood tests in the process of monitoring disease activity in patients with kidney damage. The undisputed advantages of saliva as diagnostic medium are well-known -an easily accessible testing material, non-invasive collection of samples that could be performed by the patient without the required participation of medical personnel, minimal infection risk, low cost value of the test (in laboratories routinely testing saliva). With the advance of laboratory methods, the biological contents in the oral cavity will be an increasingly preferred diagnostic medium.
